SCHEMBL6924754

SCHEMBL6924754

COC(=O)c1cc(C(=O)CBr)c(C)s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 5/20 0.50
CSNK2A2 P19784 1/20 0.40
KDR P35968 1/20 0.40
CSNK2B P67870 1/20 0.40
CSNK2A1 P68400 1/20 0.40
HPGD P15428 5/20 0.39
MAPK1 P28482 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
TSHR P16473 1/20 0.39
ATM Q13315 1/20 0.39
KDM4E B2RXH2 6/20 0.38
ALDH1A1 P00352 4/20 0.38
NPC1 O15118 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 2/20 0.37
MAPT P10636 2/20 0.37
MEN1 O00255 1/20 0.37
DAO P14920 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6925139 0.84 GSK3B (0.47) GSK3BKDM4EALDH1A1KMT2AMAPT
SCHEMBL6924226 0.83 GSK3B (0.46) GSK3BHPGDMAPK1NPSR1KDM4E
SCHEMBL6925132 0.80 KEAP1 (0.37) GSK3BCSNK2A2KDRCSNK2BCSNK2A1
SCHEMBL6928339 0.77 KDM4E (0.43) GSK3BCSNK2A2KDRCSNK2BCSNK2A1
SCHEMBL3720571 0.75 GSK3B (0.46) GSK3BMAPK1ALDH1A1KMT2AMAPT
SCHEMBL6925463 0.75 KDM4E (0.42) GSK3BCSNK2A2KDRCSNK2BCSNK2A1
SCHEMBL1529472 0.74 CSNK2A2 (0.45) CSNK2A2KDRCSNK2BCSNK2A1HPGD
SCHEMBL8182690 0.74 GSK3B (0.52) GSK3BHPGDALDH1A1KMT2AMAPT
SCHEMBL9925990 0.73 KDM4E (0.67) CSNK2A2KDRCSNK2BCSNK2A1HPGD
SCHEMBL31386371 0.73 PDGFRB (0.43) GSK3BKDRHPGDTSHRATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6515002-B2 4-(4-(1-phenyl-5-propylpyrazol4-yl)(1,3-thiazol-2-yl))-5 -methylthiothiophene-2-carboxamidine, for example; complement inhibitors; treating tissue damage, inflammation, or autoimmune diseases 3-DIMENSIONAL PHARMACEUTICALS, INC. 2003-02-04 US disclosed